LONDON (Alliance News) - Midatech Pharma PLC said Tuesday that it expects to post revenue slightly ahead of its expectations for 2014, and a year-end cash position of GBP30 million.
Revenue growth has been driven by higher-than-expected partnership income.
Midatech listed on AIM last December. It didn't say in its statementTuesday what its full-year revenue expectations are, or what its previous year end cash position was.
It is scheduled to announce its full year results April 17.
"Our focus is now on executing the strategy we set out at the time of our IPO aimed at realising the huge potential of our two platform technologies to deliver a step change in the treatment of diabetes, cancers and ophthalmic diseases," said Chief Executive Officer Jim Philips in a statement.
Shares in Midatech are trading up 3.8% at 297.50 pence Tuesday morning.
By Hana Stewart-Smith; hanassmith@alliancenews.com; @HanaSSAllNews
Copyright 2015 Alliance News Limited. All Rights Reserved.